Matrix metallopeptidase 9 (MMP9), a collagenase which digests type IV and V collagen of the extracellular matrix which has been identified as a biomarker for coronary artery disease, was found to be down-regulated in both the LV of donors and ICM vs RV83. The gene discussed is MMP9; the disease is coronary artery disorder.